Indian scientists have developed RK-251, a promising “smart” cancer drug designed to activate mainly inside cancer cells while limiting damage to healthy tissue. Developed by researchers from IASST and IIT-Guwahati, the drug showed strong activity against aggressive triple-negative breast cancer cells in preclinical studies. The breakthrough could offer a more targeted alternative to conventional chemotherapy, but human clinical trials are still needed before its safety and effectiveness can be established.


India's new 'smart' cancer drug could transform cancer treatment 

cancertreatment

Cancertreatment, News on Cancertreatment, stories on Cancertreatment, articles on Cancertreatment, Cancertreatment stories at Wion, Cancertreatment news, Cancertreatment latest news